Liabilities, Current in USD of Nurix Therapeutics, Inc. from Q4 2019 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Nurix Therapeutics, Inc. quarterly Liabilities, Current history and change rate from Q4 2019 to Q3 2025.
Nurix Therapeutics, Inc. Liabilities, Current for the quarter ending 31 Aug 2025 was $82.4M, a 4.57% decline year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Change (%)

Nurix Therapeutics, Inc. Quarterly Liabilities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$82.4M	-$3.95M	-4.57%	31 Aug 2025	10-Q	09 Oct 2025
Q2 2025	$75.6M	-$5.17M	-6.39%	31 May 2025	10-Q	09 Jul 2025
Q1 2025	$90M	+$2.37M	+2.7%	28 Feb 2025	10-Q	08 Apr 2025
Q4 2024	$95.9M	+$8.9M	+10.2%	30 Nov 2024	10-Q	09 Oct 2025
Q3 2024	$86.3M	+$24.8M	+40.3%	31 Aug 2024	10-Q	11 Oct 2024
Q2 2024	$80.8M	+$8.52M	+11.8%	31 May 2024	10-Q	11 Jul 2024
Q1 2024	$87.6M	+$22.7M	+35.1%	29 Feb 2024	10-Q	10 Apr 2024
Q4 2023	$87M	+$16.3M	+23.1%	30 Nov 2023	10-K	28 Jan 2025
Q3 2023	$61.5M	-$6.01M	-8.9%	31 Aug 2023	10-Q	12 Oct 2023
Q2 2023	$72.3M	-$403K	-0.56%	31 May 2023	10-Q	13 Jul 2023
Q1 2023	$64.9M	-$1.17M	-1.77%	28 Feb 2023	10-Q	13 Apr 2023
Q4 2022	$70.7M	+$4.4M	+6.64%	30 Nov 2022	10-K	15 Feb 2024
Q3 2022	$67.5M	+$16.8M	+33.2%	31 Aug 2022	10-Q	06 Oct 2022
Q2 2022	$72.7M	+$25.8M	+55.1%	31 May 2022	10-Q	07 Jul 2022
Q1 2022	$66M	+$18.1M	+37.7%	28 Feb 2022	10-Q	08 Apr 2022
Q4 2021	$66.3M	+$21.7M	+48.8%	30 Nov 2021	10-K	09 Feb 2023
Q3 2021	$50.7M	+$9.67M	+23.6%	31 Aug 2021	10-Q	14 Oct 2021
Q2 2021	$46.8M			31 May 2021	10-Q	13 Jul 2021
Q1 2021	$48M			28 Feb 2021	10-Q	13 Apr 2021
Q4 2020	$44.5M	+$28.4M	+176%	30 Nov 2020	10-K	28 Jan 2022
Q3 2020	$41M			31 Aug 2020	10-Q	14 Oct 2020
Q4 2019	$16.1M			30 Nov 2019	10-K	16 Feb 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.